Results 111 to 119 of about 51,156 (119)

Bone density and remodeling after discontinuation of sequential therapy for premenopausal idiopathic osteoporosis. [PDF]

Osteoporos Int
Cohen A, Kamanda-Kosseh M, Rawal R, Agarwal S, Barry J, Shiau S, Colon I, Bucovsky M, Lappe JM, Shane E.   +9 more
europepmc   +1 more source

Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.

J Clin Endocrinol Metab
Ferrari S, Betah D, Feldman RG, Langdahl BL, Oates M, Timoshanko J, Wang Z, Dhaliwal R.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

[New bone density conservation agents for osteoporosis under research and development: Ibandronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Ikuko, Tanaka, Junko, Hashimoto, Hisaji, Oshima   +2 more
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: Zoledronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Seiki, Wada, Takeshi, Fukawa, Sadahiro, Kamiya   +2 more
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Itsuro, Endo, Toshio, Matsumoto
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Seiki, Wada, Takeshi, Fukawa, Sadahiro, Kamiya   +2 more
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: ED-71].

Nihon rinsho. Japanese journal of clinical medicine, 2008
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: Minodronic acid].

Nihon rinsho. Japanese journal of clinical medicine, 2008
openaire   +1 more source